Melissa K. Carpenter
Direttore/Membro del Consiglio presso The International Society for Stem Cell Research
Profilo
Dr. Melissa K.
Carpenter is an Associate at Proteus Venture Partners LLC (Venture Capital).
Dr. Carpenter was previously employed as Vice President-Research & Development by ViaCyte, Inc. She was also employed at CytoTherapuetics, Inc. and served on the board at Geron Corp.
and CyThera, Inc.
Dr. Carpenter received her PhD in Laboratory of Cellular and Molecular Neurobiology from the University of California, Irvine.
Posizioni attive di Melissa K. Carpenter
| Società | Posizione | Inizio |
|---|---|---|
| The International Society for Stem Cell Research | Direttore/Membro del Consiglio | 18/03/2021 |
Precedenti posizioni note di Melissa K. Carpenter
| Società | Posizione | Fine |
|---|---|---|
Proteus RM LLC (Venture Capital)
 Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Investitore di Private Equity | - |
| CytoTherapuetics, Inc. | Corporate Officer/Principal | - |
CyThera, Inc.
 CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Corporate Officer/Principal | - |
| GERON CORPORATION | Corporate Officer/Principal | - |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Melissa K. Carpenter
| University of California, Irvine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| GERON CORPORATION | Health Technology |
| Aziende private | 5 |
|---|---|
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
CyThera, Inc.
CyThera, Inc. Miscellaneous Commercial ServicesCommercial Services CyThera, Inc. is a biotechnology company focused on developing cell replacement therapies for the treatment of human degenerative disease. The company's technology enables the expansion and proliferation of functional human stem cells in vitro that can be used to restore specialized tissue function. The companyis headquartered in San Diego, CA. | Commercial Services |
| CytoTherapuetics, Inc. | Finance |
Proteus RM LLC (Venture Capital)
Proteus RM LLC (Venture Capital) Investment ManagersFinance Proteus RM LLC (Venture Capital) (Proteus RM) is a venture capital subsidiary of Proteus RM LLC founded in 2006 by Gregory A. Bonfiglio. The firm is headquartered in Portola Valley, California. | Finance |
| The International Society for Stem Cell Research |
- Borsa valori
- Insiders
- Melissa K. Carpenter
